Fig 5. Kaplan-Meier plots for overall survival.
(A) Overall survival and stratified by (B) 1L regimen group, (C) patient age, (D) gender, and (E) CCI score. CCI: Charlson Comorbidity Index; OS: overall survival; R: rituximab; R-CHOP: rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
